Quick Takeaways
- Eyal Rubin has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $931,882.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Eyal Rubin
- Location
- Hackensack, NJ
- Summary
- The estimated net worth of Eyal Rubin is at least $931,882 dollars as of 27 Mar 2026. Eyal Rubin is the Sr. VP and CFO of Protalix BioTherapeutics, Inc. and owns shares of Protalix BioTherapeutics, Inc. (PLX) stock worth about $931.9K.
- Signature
- /s/ Eyal Rubin
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Eyal Rubin and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Protalix BioTherapeutics, Inc. ($931,882).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Eyal Rubin
PLX
Forms 3/4/5
Protalix BioTherapeutics, Inc.
- Relationship
- Sr. VP and CFO
- Holdings value
- $931,882
- Past year net change
- Change %
- Report period
- 23 Sep 2024
NSRX
Forms 3/4/5
Nasus Pharma Ltd
- Relationship
- Chief Financial Officer, EVP
- Holdings value
- Past year net change
- Change %
- Report period
- 18 Mar 2026
Insider Transactions Reported by Eyal Rubin:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.